搜索筛选:
搜索耗时1.9155秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
发布年度:
[会议论文] 作者:Pei Guoxi,
来源:The Forth BEPCII IMAC Meeting 年份:2006
...
[会议论文] 作者:Han Pei,Hu Yunquan,
来源:第二届中药现代化新剂型新技术国际学术会议 年份:2006
Traditional Chinese medicine has some special advantages for dealing with the unexpected events on epidemic disease.On the basis of analyzing the problems for traditional Chinese medicine at present,...
NIFEVIROC,a New and Potent Small-molecule Inhibitor Targeted at the Human Immunodeficiency Virus Typ
[会议论文] 作者:Li Chen,Gang Pei,Linqi Zhang,
来源:2006中国天津世界艾滋病日科技会议 年份:2006
NIFEVIROC,a small molecular compound,is a proprietary drug candidate which is developed by TARGETDRUG and holds great promise in inhibiting HIV-1 replicatio...
[会议论文] 作者:江伟,王成山,余贻鑫,ZHANG Pei,
来源:福建省电机工程学会第六届年会、第二届青年学术年会——省科协第六届学术年会 年份:2006
文中提出一种降阶求解静态电压稳定临界点的新技术.其特点是原直接法的(2n+1)维牛顿迭代方程组可降阶为(n+1)维线性方程组求解.与解高维方程的传统直接法相比该方法计算量小、易于采用稀疏技术实现,适合于大规模电力系统电压稳定临界点的在线求解.另外,还提出一......
NIFEVIROC,a new and potent small-molecule inhibitor targeted at the human immunodeficiency virus typ
[会议论文] 作者:Li Chen,Gang Pei,Dawei Ma,Renhai Chen,Li Liu,Qing Fang,Zhiwei Chen,Linqi Zhang,
来源:中国科协青年科学家论坛暨2006年第二届新生病毒性疾病控制学术研讨会 年份:2006
NIFEVIROC, a small molecular compound, is a proprietary drug candidate which is developed by TARGETDRUG and holds great promise in inhibiting HIV-1 replication in infected paitents.Preclinical studies...
[会议论文] 作者:Ke Ning,Qi Wan,Mingxia Liao,Lei Li,James Eubanks,Lin Pei,Fang Liu,Yunzhou Zhang,Wen Jiang,Xia Zhang,John,
来源:4th International Neuroscience Symposium in China(第四届海内外华人神经 年份:2006
...
[会议论文] 作者:Ke Ning,James Eubanks,Qi Wan,Lin Pei,Mingxia Liao,Yunzhou Zhang,Wen Jiang,John G.Mielke,Lei Li,Xia Zhang,
来源:4th International Neuroscience Symposium in China(第四届海内外华人神经 年份:2006
...
相关搜索: